Meshke Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 7 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth 72.26%
- Profit Growth 35.69%
- Ebitda 24.10%
- Net Worth -28.25%
- Total Assets 19.76%
About Meshke Biotech
Meshke Biotech Private Limited (MBPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 July 2013 and has a history of 11 years and seven months. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sooraj Dharmalayam, Rajesh Padmanabhan, and Madhu Kuttamballi serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51397KA2013PTC070047
- Company No.
070047
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jul 2013
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Meshke Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sooraj Dharmalayam  | Managing Director | 09-Jul-2013 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Madhu Kuttamballi | Director | 19-Jul-2013 | Current |
| Rajesh Padmanabhan | Director | 09-Jul-2013 | Current |
Financial Performance of Meshke Biotech.
Meshke Biotech Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 72.26% increase. The company also saw a substantial improvement in profitability, with a 35.69% increase in profit. The company's net worth observed a substantial decline by a decrease of 28.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Meshke Biotech?
In 2017, Meshke Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Meshke Biotech?
Unlock and access historical data on people associated with Meshke Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Meshke Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Meshke Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.